<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Survival Analysis of Treatment Effect on Cirrhosis</title>

<script src="site_libs/header-attrs-2.16/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/yeti.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-9.12.0/default.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>
<link href="site_libs/font-awesome-5.1.0/css/all.css" rel="stylesheet" />
<link href="site_libs/font-awesome-5.1.0/css/v4-shims.css" rel="stylesheet" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>









<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "&#xe258;";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Home</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="about.html">About Me</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Projects
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="patient_portal.html">Patient Portal App Review Analysis</a>
    </li>
    <li>
      <a href="https://lscelia.github.io/Smoking_in_US/index.html">Do You Smoke?</a>
    </li>
  </ul>
</li>
<li>
  <a href="mailto:lh3109@caa.columbia.edu">
    <span class="fa fa-envelope fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="http://github.com/lscelia/">
    <span class="fa fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">Survival Analysis of Treatment Effect on
Cirrhosis</h1>

</div>


<p>Group 1: Fiona Li, Peilin Zhou, Lesi He, Hao Zheng, Yihan Qiu<br />
</p>
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>Each year, approximately one million deaths are due to complications
of cirrhosis, making cirrhosis the 11th most common cause of death
globally [1]. Cirrhosis is a late stage of scarring (fibrosis) of the
liver caused by long-term liver damage. Causes of cirrhosis include
alcoholism, problems affecting the bile ducts, immune system inherited
conditions and long-term use of certain medicines. Generally, there is
no effective cure for cirrhosis for now, however, there are ways that
may be able to stop cirrhosis from getting worse, such as healthy
lifestyle and treating the problem that led to cirrhosis.</p>
<p>D-penicillamine, which primarily can decrease hepatic copper by
increasing urinary copper excretion, inhibit fibrogenesis and prevent
the appearance of scar lesions in the liver, is used for patients with
primary biliary cirrhosis. However, for patients who are recommended to
take emergency liver transplantation, D-penicillamine is debated whether
it’s effective with treating acute liver failure [4,5]. Our project aims
to investigate whether taking D-penicillamine or not can affect the
survival rate of cirrhosis patients.<br />
<br />
</p>
</div>
<div id="data" class="section level2">
<h2>Data</h2>
<p>The <a
href="https://www.kaggle.com/datasets/fedesoriano/cirrhosis-prediction-dataset">Cirrhosis
Prediction Dataset</a> contains the information of 424 patients with
primary biliary cirrhosis collected from the Mayo Clinic trial between
1974 and 1984. After data cleaning process, 276 patients are remained
for further analysis</p>
<p><img src="figures/data%20summary.png" /><br />
 </p>
</div>
<div id="eda" class="section level2">
<h2>EDA</h2>
<p><img src="figures/corr.png" /></p>
</div>
<div id="methods-results" class="section level2">
<h2>Methods &amp; Results</h2>
<div id="life-table" class="section level3">
<h3>Life Table</h3>
<p>Life table is an approach commonly used in survival analysis to
describe the mortality experience of a cohort of people.It is used in
continuous survival data. Here, we created life tables for
D-penicillamine (treatment) and placebo (control) groups:<br />
<br />
D-penicillamine:<br />
<img src="figures/trt%20life%20table.png" width="60%"/><br />
<br />
Placebo:<br />
<img src="figures/ctrl%20life%20table.png" width="60%"/></p>
<p>The median survival time for D-penicillamine (Treatment) is 8.5
years, and the median survival time for placebo (Control) is 9.4
years.<br />
<br />
</p>
</div>
<div id="km" class="section level3">
<h3>KM</h3>
<p><img src="figures/KM.png" /></p>
<p><br />
</p>
</div>
<div id="log-rank-test" class="section level3">
<h3>Log-rank Test</h3>
<p>We performed a log-rank test comparing D-penicillamine (Treatment)
and Placebo (Control):<br />
* Null Hypothesis: there is no difference in survival distributions
between treatment and control groups.<br />
* Alternative Hypothesis: there is significant difference in survival
distributions between treatment and control groups. Significance level:
alpha = 0.05<br />
<br />
<img src="figures/logrank%20table.png" width="60%"/></p>
<p><br />
Since p-value = 0.5 &gt; 0.05, we fail to reject the null hypothesis and
conclude that there is no difference between the populations in the
probability of an event (death) at any time point between treatment and
control groups.<br />
<br />
</p>
</div>
<div id="cox-ph-model" class="section level3">
<h3>Cox PH Model</h3>
<p>To evaluate simultaneously the effect of several factors on the
hazard rate of a particular event at a particular point in time, we
utilized the COX PH Model.Here are the steps:<br />
1. Fit a full model<br />
2. Perform backward stepwise variable selection (AIC)<br />
3. Refit model with selected variables and treatment variable 4. Check
model assumptions with schoenfeld residual test and plot<br />
5. Add time-varying covariates/stratification and check assumptions
again<br />
6. Fit final model<br />
<br />
After performing variable selection, the variables are reduced to:
treatment, age, edema, bilirubin, albumin, copper, sgot, prothrombin,
stage (Treatment variable is kept in the model for research
purpose).<br />
<br />
</p>
<p>We checked the model assumption through Schoenfeld residual
test:<br />
<img src="figures/bili.png" width="30%"/>
<img src="figures/pro.png" width="30%"/>
<img src="figures/check_assump%20table.png" width="30%"/></p>
<p>As shown in the plots, Bilirubin and prothrombin seem to be
time-dependent: from the start of the study to around 1100 days, and
from 1100 days to the end of study. Hence, we needed to fit a cox model
with time-varying coefficients</p>
<p>Our final model is stratified by time group and interact with the two
covariates. From the table, we can see that the treatment variable is
not statistically significant to the model (p value = 0.67)<br />
<img src="figures/final_model.png" width="60%"/></p>
<p>Interpreting the table, we can see that:<br />
</p>
<ul>
<li>Bilirubin variable in time group 1 has a hazard ratio of 1.07 and
its hazard ratio increases to 1.20 in time group 2 (both have p value
smaller than 0.05), indicating that patients with lower serum bilirubin
level are more likely to survive.</li>
<li>Prothrombin variable:
<ul>
<li>From the start of the study to 1100 days (time group = 1), it has a
hazard ratio of 1.57 with a p value &lt; 0.05, suggesting that patients
with shorter prothrombin time (in seconds) are more likely to
survive;</li>
<li>From the 1100th day to the end of the study (time group = 2), its
hazard ratio has a p value larger than 0.05, suggesting that this
variable is not statistically significant.</li>
</ul></li>
<li>Albumin variable has hazard ratio of 0.49 with a p value &lt; 0.05,
indicating that the patients with relatively higher albumin level are
more likely to survive.</li>
<li>EdemaY variable has a hazard ratio of 2.53 with a p value &lt; 0.05,
suggesting that the patients who have edema despite diuretic therapy
have higher risk of death comparing to those without edema.<br />
<br />
</li>
</ul>
</div>
</div>
<div id="conclusion" class="section level2">
<h2>Conclusion</h2>
<p>The drug D-penicillamine does not have statistically significant
contribution to improve the survival rate of cirrhosis patients.
Maintaining a normal range of serum albumin level (3.8 to 5.1g/dl) is
crucial for lowering the risk of death for cirrhosis patients<br />
<br />
</p>
</div>
<div id="discussion" class="section level2">
<h2>Discussion</h2>
<p>The log-rank test is purely a significance test and cannot provide an
estimate of the size of the difference between the groups and its
related confidence interval. In this project, liver transplant is
considered as a censoring event. The K-M estimator can lead to
overestimation of cumulative incidence. An alternative method, competing
risk regression, can be applied to this dataset to deal with this
problem in the future.<br />
<br />
</p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Asrani SK, Devarbhavi H, Eaton J, Kamath PS (January 2019).
“Burden of liver diseases in the world”. Journal of Hepatology. 70 (1):
151–171.<br />
[2] Villarroel MA, Blackwell DL, Jen A. Tables of Summary Health
Statistics for U.S. Adults: 2018 National Health Interview Survey.
National Center for Health Statistics. 2019. Available from: <a
href="http://www.cdc.gov/nchs/nhis/SHS/tables.html"
class="uri">http://www.cdc.gov/nchs/nhis/SHS/tables.html</a><br />
[3] Centers for Disease Control and Prevention, National Center for
Health Statistics. National Vital Statistics System, Mortality 1999-2020
on CDC WONDER Online Database, released in 2021. Data are from the
Multiple Cause of Death Files, 1999-2020, as compiled from data provided
by the 57 vital statistics jurisdictions through the Vital Statistics
Cooperative Program. Accessed at <a
href="http://wonder.cdc.gov/ucd-icd10.html"
class="uri">http://wonder.cdc.gov/ucd-icd10.html</a><br />
[4] Bellary S, Hassaneim T, Van Thiel DH (1995) Liver transplantation
for Wilson’s disease. J Hepatol 23:373–381. / [5] Stampfl DA, Munoz SJ,
Moritz MJ, et al. (1990) Heterotopic liver transplantation for fulminant
Wilson’s disease. Gastroenterology 99:1834–1836.<br />
[6] fedesoriano. (August 2021). Cirrhosis Prediction Dataset. Retrieved
[Date Retrieved] from <a
href="https://www.kaggle.com/fedesoriano/cirrhosis-prediction-dataset"
class="uri">https://www.kaggle.com/fedesoriano/cirrhosis-prediction-dataset</a>.<br />
[7] Stel, V.S. et al. (2011) Survival analysis I: The kaplan-meier
method, Nephron Clinical Practice. Karger Publishers. Available at: <a
href="https://www.karger.com/Article/Fulltext/324758#"
class="uri">https://www.karger.com/Article/Fulltext/324758#</a>:~:text=A%20limitation%20of%20the%20KM,and%20its%20related%20confidence%20interval.
(Accessed: December 3, 2022).<br />
</p>
</div>




</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
